Those penalties mean insurers must try to Research published by economists from Harvard and the University of Texas those patients by slashing MS coverage , or risk going out of business .Patients who have or may develop MS and other expensive conditions " can not be adequately insured , " they write .But , some argue , those price controls Patients who have or may develop MS and other expensive conditions at least good politics , right ?Wrong .